<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WYO2BUA6</identifier><date>2017</date><creator>Benedik, Jernej</creator><creator>Boc, Marko</creator><creator>Ebert Moltara, Maja</creator><creator>Hlebanja, Zvezdana</creator><creator>Mesti, Tanja</creator><creator>Ocvirk, Janja</creator><creator>Reberšek, Martina</creator><creator>Volk, Neva</creator><relation>documents/doc/W/URN_NBN_SI_doc-WYO2BUA6_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WYO2BUA6_001.txt</relation><format format_type="extent">35 str., 25 cm</format><identifier identifier_type="COBISSID_HOST">2624379</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WYO2BUA6</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>knjige</source><rights>InC</rights><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">panitumumab</subject><subject language_type_id="slv">rak debelega črevesa</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Panitumumab</title><title>vodnik pri zdravljenju raka debelega črevesa in danke z zdravilom panitumumab</title></Record>